These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

761 related items for PubMed ID: 11093446

  • 1. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.
    Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N.
    J Rheumatol; 2000 Nov; 27(11):2635-41. PubMed ID: 11093446
    [Abstract] [Full Text] [Related]

  • 2. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
    Detora LM, Krupa D, Bolognese J, Sperling RS, Ehrich EW.
    J Rheumatol; 2001 Nov; 28(11):2494-503. PubMed ID: 11708424
    [Abstract] [Full Text] [Related]

  • 3. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A, Ma C, Ahdieh H, Galer BS.
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [Abstract] [Full Text] [Related]

  • 4. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial.
    Lambert RG, Hutchings EJ, Grace MG, Jhangri GS, Conner-Spady B, Maksymowych WP.
    Arthritis Rheum; 2007 Jul; 56(7):2278-87. PubMed ID: 17599747
    [Abstract] [Full Text] [Related]

  • 5. Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis.
    Ehrich EW, Bolognese JA, Watson DJ, Kong SX.
    Am J Manag Care; 2001 Jun; 7(6):609-16. PubMed ID: 11439734
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement.
    Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M.
    Ann Rheum Dis; 2005 Jan; 64(1):29-33. PubMed ID: 15208174
    [Abstract] [Full Text] [Related]

  • 7. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial.
    Gibofsky A, Williams GW, McKenna F, Fort JG.
    Arthritis Rheum; 2003 Nov; 48(11):3102-11. PubMed ID: 14613272
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
    Schnitzer TJ, Weaver AL, Polis AB, Petruschke RA, Geba GP, VACT-1 and VACT-2 (Protocols 106 and 150) Study Groups.
    J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774
    [Abstract] [Full Text] [Related]

  • 9. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR, Benson GD, Zinsenheim JR, Schweinle JE.
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee.
    Babul N, Noveck R, Chipman H, Roth SH, Gana T, Albert K.
    J Pain Symptom Manage; 2004 Jul; 28(1):59-71. PubMed ID: 15223085
    [Abstract] [Full Text] [Related]

  • 11. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients.
    Vorsanger G, Xiang J, Jordan D, Farrell J.
    Clin Ther; 2007 Jul; 29 Suppl():2520-35. PubMed ID: 18164919
    [Abstract] [Full Text] [Related]

  • 12. The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis.
    Pope JE, Prashker M, Anderson J.
    J Rheumatol; 2004 Jan; 31(1):140-9. PubMed ID: 14705233
    [Abstract] [Full Text] [Related]

  • 13. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.
    Altman RD, Moskowitz R.
    J Rheumatol; 1998 Nov; 25(11):2203-12. PubMed ID: 9818665
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ, Kivitz AJ, Lipetz RS, Sanders N, Hee A.
    Arthritis Rheum; 2005 Dec 15; 53(6):827-37. PubMed ID: 16342089
    [Abstract] [Full Text] [Related]

  • 15. Precision of composite measures of osteoarthritis efficacy in comparison to that of individual endpoints.
    Bolognese JA, Ehrich EW, Schnitzer TJ.
    J Rheumatol; 2001 Dec 15; 28(12):2700-4. PubMed ID: 11764220
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.
    Birbara C, Ruoff G, Sheldon E, Valenzuela C, Rodgers A, Petruschke RA, Chang DJ, Tershakovec AM.
    Curr Med Res Opin; 2006 Jan 15; 22(1):199-210. PubMed ID: 16393445
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials.
    Biegert C, Wagner I, Lüdtke R, Kötter I, Lohmüller C, Günaydin I, Taxis K, Heide L.
    J Rheumatol; 2004 Nov 15; 31(11):2121-30. PubMed ID: 15517622
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
    Emkey R, Rosenthal N, Wu SC, Jordan D, Kamin M, CAPSS-114 Study Group.
    J Rheumatol; 2004 Jan 15; 31(1):150-6. PubMed ID: 14705234
    [Abstract] [Full Text] [Related]

  • 19. The factor subdimensions of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) help to specify hip and knee osteoarthritis. a prospective evaluation and validation study.
    Angst F, Ewert T, Lehmann S, Aeschlimann A, Stucki G.
    J Rheumatol; 2005 Jul 15; 32(7):1324-30. PubMed ID: 15996072
    [Abstract] [Full Text] [Related]

  • 20. Individualising the Western Ontario and McMaster Universities osteoarthritis index (WOMAC) function subscale: incorporating patient priorities for improvement to measure functional impairment in hip or knee osteoarthritis.
    Seror R, Tubach F, Baron G, Falissard B, Logeart I, Dougados M, Ravaud P.
    Ann Rheum Dis; 2008 Apr 15; 67(4):494-9. PubMed ID: 17704063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.